News

Europe is a “second class continent” for cancer research

BMJ 2005; 330 doi: 10.1136/bmj.330.7494.746-b (Published 31 March 2005)
Cite this as: BMJ 2005;330:746.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Rory Watson
  1. Brussels

    Funding for cancer research in the European Union lags far behind that in the United States and varies enormously from one EU country to another, a new survey by the European Cancer Research Managers Forum shows.

    Produced with the support of the European Commission, the survey is the first comprehensive analysis of cancer research funding in Europe. It identified 139 sources of non-commercial financing that provided €1.43bn (£1bn; …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular